Dansk Lunge Cancer Register har leveret data til eller bidraget til følgende publikationer:

  1. Jakobsen E, Palshof T. et al.: Data from a national lung cancer registry contributes to improve outcome an quality of surgery: Danish results. Car.thor. sur. 2009, 35 (2): 348-52
  2. Wildgaard K, Ravn J, et al.: Consequences of persistent pain after lung cancer surgery: a nationwide questionnaire study. Acta Anaesthesiol Scan 2011 55:60-68
  3. Dalton SO, Frederiksen BL et al.: Socioeconomic position, stage of lung cancer and time between referral and diagnosis in Denmark, 2001-2008 BJC (2011) 105, 1042-1048
  4. Lipczak H., Neckelmann K. et al.: Uncertain added value of global Trigger Tool for monitoring of patient safety in cancer care. Dan Med Bul 58/11
  5. Lüchtenborg M. et al: The effect of comorbidity on stage-specific survival in resected non-small cell lung cancer patients. European Journal of Cancer 2012;48(18):3386-95
  6. Jakobsen E. et al: Dansk Lunge Cancer Register. Ugeskr Læger 174/42, 2012; 2539
  7. Starr L. et al.: Socioeconomic position and surgery for early-stage non small cell lung cancer: a population-based study in Denmark. Lung Cancer 79 (2013) 262– 269
  8. Walters S. et al: Lung cancer survival and stage at diagnosis in Australia, Canada, Denmark, Norway, Sweden and the United Kingdom: a population-based study, 2004- 2007. Thorax 2013;0:1–14
  9. Licht P.B. et al: A National Study of Nodal Upstaging After Thoracoscopic Versus Open Lobectomy for Clinical Stage-1 Lung Cancer. Afp. in Annals of Thorcic Surgery
  10. Jakobsen E. et al: Nationwide quality improvement in lung cancer care: The Danish Lung Cancer Registry. in Journal of Thoracic Oncology
  11. Lüchtenborg M. et al: High procedure volume is strongly associated with improved survival after lung cancer surgery. Afp. in Journal of Clinical Oncology
  12. Ledderer L. et al: Feasibility of a psychosocial rehabilitation intervention to enhance the involvement of relatives in cancer rehabilitation. Pilot study for a randomized controlled trial. Sfp. in The Patient: Patient–Centered Outcomes Research
  13. Lüchtenborg M. et al: Survival of small cell lung cancer patients undergoing lung resection in England 1998- 2009. BMJ  2013
  14. Søgaard R., Fischer BM., Mortensen J., Rasmussen TR., Lassen U.: The Optimality of Different Strategies for Supplemental Staging of Non–Small-Cell Lung Cancer: A Health Economic Decision Analysis. Value in Health 16 (2013): 57-65
  15. Lüchtenborg M., Jakobsen E., Peake M.D., Møller H.: Mortality after surgery for Small Cell Lung Cancer. Thorax 2013;0:1–5
  16. Jakobsen E., Green A.: Benchmarking Consortium: Lungekræft 2000 – 2012 
  17. Iachina M., Green A., Jakobsen E. et al.: The direct and indirect impact of comorbidity on the survival of patients with non-small cell lung cancer: a combination of survival, staging and resection models with missing measurements in covariates. BMJ Open 2014;4:e003846
  18. Blum T., Jakobsen E. et al: ERS task force report: The European Initiative for Quality Management in Lung Cancer Care. The European Respiratory Journal 2014/03
  19. Licht P., Schytte T., Jakobsen E.: Adjuvant Chemotherapy Compliance  Is Not superior After Thoracoscopic Lobectomy. Ann Thorac Surg. 2014 Aug;98(2):411-5; discussion 415-6
  20. Skov B.G, Høgdal E. et al.: The prevalence of EGFR mutations in non-small cell lung cancer in an unseleted Caucasian population APMS 123: 108-116
  21. Rami-Porta R, Bolejack V, Giroux DJ, Chansky K, Crowley J, Asamura H, Goldstraw P; International Association for the Study of Lung Cancer Staging and Prognostic Factors Committee, Advisory Board Members and Participating Institutions.: The IASLC lung cancer staging project: the new database to inform the eighth edition of the TNM classification of lung cancer. J Thorac Oncol. 2014 Nov;9(11):1618-24
  22. Mellemgaard A., Lüchtenborg M. et al: Role of comorbidity on survival after radio- and chemotherapy for non-surgically treated lung cancer. J Thorac Oncol. 2015 Feb;10(2):272-9
  23. Iachina M., Jakobsen E. et al: The Effect of Different Comorbidities on Survival of Non-small Cells Lung Cancer Patients. Lung 2015 193:291–297
  24. Laursen LØ, Petersen RH et al: Video-assisted thoracoscopic surgery lobectomy for lung cancer is associated with a lower 30-day morbidity compared with lobectomy by thoracotomy. Eur J Cardiothoracic Surg (2015); 49(3):870-5
  25. Dalton S, Steding-Jessen M et al.: Socioeconomic position and survival after lung cancer – the influence of stage, treatment and comorbidity among Danish lung cancer patients diagnosed 2004-2010. Acta Oncol.2015 May;54(5):797-804
  26. Green A., Hauge J. et al: The mortality after surgery in primary lung cancer: results from the Danish Lung Cancer Registry. European Journal of Cardio-Thoracic Surgery (2015); 49(2): 589-94
  27. Jakobsen E., Rasmussen T.R.: The Danish Lung Cancer Registry. Clinical Epidemiology (2016) publicated online
  28. Jakobsen E., Riis Rasmussen T. et al: Mortality and survival of Lung Cancer in Denmark: Results from the Danish Lung Cancer Group 2002-2012. Acta Oncologica (2016) 1-8
  29. O´Dowd EL, Lüchteenborg M et al: Predicting death from surgery for lung cancer. A comparison of two scoring systems in two European countries. Lung Cancer (2016)95, 88-93
  30. Møller H., Riaz SP et al: High lung cancer surgical procedure volume is associated with shorter length of stay and lower risks of readmission and death: national cohort analysis in England. Accepted for publication in European Journal of Cancer
  31. Jakobsen E., Rasmussen T.R.: The Danish Lung Cancer Registry. Clinical Epidemiology 2016:8 537-541
  32. Møller H., Jakobsen E et al: High lung cancer surgical procedure volume is associated with shorter length of stay and lower risks of readmission and death: national cohort analysis in England. Eur J Cancer. 2016 Sep;64:32-43
  33. Guldbrandt LM, Møller H, et al: General practice consultations, diagnostic investigations and prescriptions in the year preceding a lung cancer diagnosis. Cancer Medicine 2017; 6(1):79–88
  34. Eckardt J, Jakobsen E, et al: Subcarinal Lymph Node Schould be Dissection in All Lobectomies for Non-Small Cell Lung Cancer – Regardless of Primary Tumor Location Ann Thorac Surg 2017;103:1121–5
  35. Iachina M., Brønserud MM, et al.: History of Depression in Lung Cancer Patients: Impact of delay. Clinical Oncology 2017 Sep;29(9):585-592
  36. Iachina M, Green A, et al.: Transfer between hospitals as a predictor of delay in diagnosis and treatment of patients with Non-Small Cell Lung Cancer – a register based cohort-study. BMC Health Services Research 2017 Apr 12;17(1):267
  37. Rich A., Baldwin D, et al.: Achieving Thoracic Oncology data collection in Europe: a precursor study in 35 Countries, BMC Cancer (2019) 18:114
  38. Jeppesen SS, Hansen NCG et al.: Survival of localized NSCLC patients without active treatment or treated with SBRT. Acta Oncologica 2018 Feb;57(2):219-225
  39. Rich A.L, Baldwin D.R, et al.: ERS Statement on harmonised standards for lung cancer registration and lung cancer services in Europe. European Respiratory Journal 2018
  40. Møller, H, Goupland V.H, et al.: Geographical variations in the use og cancer treatments are associated with survival of lung cancer patients. Thorax 2018;0:1-8 
  41. Christensen N.L, Kejs A.M.T. et al.: Early death in Danish stage I lung cancer patients: a population-based case study. Acta Oncologica 2018 vol. 57:1561-1566
  42. Brønserud M.M, Iachina M, et al.: Patient-reported outcomes (PROs) in lung cancer: Excperiences from a nationwide feasibility study. Lung Cancer 128 (2019) 67-73
  43. Brønserud M.M, Iachina M, et al.: Patient reported outcome data as performance indicators in surgically treated lung cancer patients. Lung Cancer 130 (2019) 143-148
  44. Christensen N.L, Dalton S, et al.: Treatment, no treatment and early death in Danish stage I lung cancer patients. Lung Cancer 131 (2019) 1-5
  45. Christensen J, Jakobsen E. et al: Agreement between The Danish Cancer Registry and The Danish Lung Cancer Registry. Dan Med J 2020;67(8):A04190257
  46. Dansk Lunge Cancer Register (DLCR) – Resumé af Årsrapport 2018. Ugeskrift Læger 182/1

  47. Skougaard K, Østrup O, Guldbrandsen K, Sørensen B, Meldgaard P, Saghir Z, Gørtz P, Lonsdale MN, Frank MS, Gerke O, Rychwicka-Kielek BA, Persson G, Land LH, Schytte T, Bodtger U, Skuladottir H, Søgaard J, Nielsen SS, Rasmussen TR, Fischer BM. Surveillance With PET/CT and Liquid Biopsies of Stage I-III Lung Cancer Patients After Completion of Definitive Therapy: A Randomized Controlled Trial (SUPER). Clin Lung Cancer. 2020 Mar;21(2):e61-e64. doi: 10.1016/j.cllc.2019.11.002. Epub 2019 Nov 21. PMID: 31839533

  48. Christensen NL, Rasmussen TR, Hansen KH, Christensen J, Dalton SO. Comorbidity and early death in Danish stage I lung cancer patients – an individualised approach. Acta Oncol. 2020 Aug;59(8):994-1001. doi: 10.1080/0284186X.2020.1764096. Epub 2020 May 28. PMID: 3246334
  49. Mouritzen MT, Carus A, Ladekarl M, Meldgaard P, Nielsen AWM, Livbjerg A, Larsen JW, Skuladottir H, Kristiansen C, Wedervang K, Schytte T, Hansen KH, Østby AC, Frank MS, Lauritsen J, Sørensen JB, Langer SW, Persson GF, Andersen JL, Frary JMC, Drivsholm LB, Vesteghem C, Christensen HS, Bjørnhart B, Pøhl M. Nationwide Survival Benefit after Implementation of First-Line Immunotherapy for Patients with Advanced NSCLC-Real World Efficacy. Cancers (Basel). 2021 Sep 28;13(19):4846. doi: 10.3390/cancers13194846. PMID: 34638329; PMCID: PMC8507718
  50. Dansk Lunge Cancer Register (DLCR) – Resumé af Årsrapport 2019-2020. Ugeskrift Læger